Noxopharm Limited (ASX:NOX)
0.0370
+0.0010 (2.78%)
Nov 20, 2026, 4:10 PM AEDT
Noxopharm Market Cap
Noxopharm has a market cap or net worth of 12.36 million as of November 19, 2026. It is the 42,383rd most valuable company in the world and the 1,225th biggest in Australia. Its market cap has decreased by 55.47% in one year.
Market Cap
12.36M
Enterprise Value
16.64M
Revenue
1.43M
Global Rank
Country Rank
#1,225 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since August 9, 2016, Noxopharm's market cap has decreased from 13.91M to 12.36M, a decrease of -11.11%. That is a compound annual growth rate of -1.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 12.36M | -54.52% |
| Dec 31, 2025 | 27.18M | - |
| Dec 31, 2024 | 27.18M | 30.99% |
| Dec 29, 2023 | 20.75M | -51.03% |
| Dec 30, 2022 | 42.37M | -62.82% |
| Dec 31, 2021 | 113.97M | -9.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Radiopharm Theranostics | 17.35M |
| Miro Sciences | 16.76M |
| Proteomics International Laboratories | 15.38M |
| Imugene | 15.18M |
| Ceryvyn Therapeutics | 15.05M |
| EZZ Life Science Holdings | 13.65M |
| Patrys | 12.81M |
| ReNerve | 12.06M |